Abstract Details
Ignacio Illan-Gala, Sr., MD, PhD
(Hospital de la Santa Creu i Sant Pau)
PRESENTER |
Dr. Illan-Gala has nothing to disclose. |
Victor Montal | No disclosure on file |
No disclosure on file | |
Neus Falgàs Martínez (UCSF) | Neus Falgàs Martínez has nothing to disclose. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Daniel Alcolea Rodriguez (Hospital Sant Pau) | Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fujirebio Europe. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Fujirebio Europe. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Daniel Alcolea Rodriguez has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nutricia. The institution of Daniel Alcolea Rodriguez has received research support from Fujirebio - Europe. Daniel Alcolea Rodriguez has received intellectual property interests from a discovery or technology relating to health care. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Rafael G. Blesa, MD (Hospital De La Santa Creu I Sant Pau) | Dr. Blesa has nothing to disclose. |
Howard J. Rosen, MD (UCSF) | Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Alector that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities. |
Bruce L. Miller, MD, FAAN (University of California, San Francisco) | Dr. Miller has nothing to disclose. |
Maria Luisa Gorno Tempini, MD, PhD (UCSF Memory and Aging Center) | The institution of Dr. Gorno Tempini has received research support from NIH. |
No disclosure on file | |
Alberto Lleo, MD (Hospital De La Santa Creu I Sant Pau) | Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Lleo has received research support from Instituto de Salud Carlos III. The institution of Dr. Lleo has received research support from Generalitat de Calalunya (PERIS). The institution of Dr. Lleo has received research support from BBVA Foundation. The institution of Dr. Lleo has received research support from La Caixa Foundation. Dr. Lleo has received intellectual property interests from a discovery or technology relating to health care. |
Juan Fortea, MD, PhD (Hospital of Sant Pau) | Dr. Fortea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Inmune. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Fortea has received research support from NIH. Dr. Fortea has received intellectual property interests from a discovery or technology relating to health care. |